A Novel Method for Quantifying Intestinal Inflammatory Burden in Inflammatory Bowel Disease Using Register Data

References

• Ungaro R, Mehandru S, Allen PB, et al. Ulcerative colitis. Lancet. 2017;389:1756–1770. doi:10.1016/S0140-6736(16)32126-227914657
   PubMed Web of Science ®Google Scholar
• Torres J, Mehandru S, Colombel J-F, et al. Crohn’s disease. Lancet. 2017;389:1741–1755. doi:10.1016/S0140-6736(16)31711-127914655
   PubMed Web of Science ®Google Scholar
• Axelrad JE, Lichtiger S, Yajnik V. Inflammatory bowel disease and cancer: the role of inflammation, immunosuppression, and cancer treatment. World J Gastroenterol. 2016;22:4794–4801. doi:10.3748/wjg.v22.i20.479427239106
   PubMed Web of Science ®Google Scholar
• Lichtenstein GR, Loftus EV, Isaacs KL, et al. ACG clinical guideline: management of Crohn’s disease in adults. Am J Gastroenterol. 2018;113:481–517. doi:10.1038/ajg.2018.2729610508
   PubMed Web of Science ®Google Scholar
• Rubin DT, Ananthakrishnan AN, Siegel CA, et al. ACG clinical guideline: ulcerative colitis in adults. Am J Gastroenterol. 2019;114:384–413. doi:10.14309/ajg.000000000000015230840605
   PubMed Web of Science ®Google Scholar
• Shah SC, Colombel J-F, Sands BE, et al. Mucosal healing is associated with improved long-term outcomes of patients with ulcerative colitis: a systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2016;14:1245–1255.e8. doi:10.1016/j.cgh.2016.01.01526829025
   PubMed Web of Science ®Google Scholar
• Rutter M, Saunders B, Wilkinson K, et al. Severity of inflammation is a risk factor for colorectal neoplasia in ulcerative colitis. Gastroenterology. 2004;126:451–459. doi:10.1053/j.gastro.2003.11.01014762782
   PubMed Web of Science ®Google Scholar
• Lichtenstein GR, Rutgeerts P. Importance of mucosal healing in ulcerative colitis. Inflamm Bowel Dis. 2010;16:338–346. doi:10.1002/ibd.2099719637362
   PubMed Web of Science ®Google Scholar
• Falvey JD, Hoskin T, Meijer B, et al. Disease activity assessment in IBD: clinical indices and biomarkers fail to predict endoscopic remission. Inflamm Bowel Dis. 2015;21:824–831. doi:10.1097/MIB.000000000000034125738372
   PubMed Web of Science ®Google Scholar
• Pineton de Chambrun G, Peyrin-Biroulet L, Lémann M, et al. Clinical implications of mucosal healing for the management of IBD. Nat Rev Gastroenterol Hepatol. 2010;7:15–29. doi:10.1038/nrgastro.2009.20319949430
   PubMed Web of Science ®Google Scholar
• Rosenberg L, Nanda KS, Zenlea T, et al. Histologic markers of inflammation in patients with ulcerative colitis in clinical remission. Clin Gastroenterol Hepatol. 2013;11:991–996. doi:10.1016/j.cgh.2013.02.03023591275
   PubMed Web of Science ®Google Scholar
• Bryant RV, Burger DC, Delo J, et al. Beyond endoscopic mucosal healing in UC: histological remission better predicts corticosteroid use and hospitalisation over 6 years of follow-up. Gut. 2016;65:408–414. doi:10.1136/gutjnl-2015-30959825986946
   PubMed Web of Science ®Google Scholar
• Bessissow T, Lemmens B, Ferrante M, et al. Prognostic value of serologic and histologic markers on clinical relapse in ulcerative colitis patients with mucosal healing. Am J Gastroenterol. 2012;107:1684–1692. doi:10.1038/ajg.2012.30123147523
   PubMed Web of Science ®Google Scholar
• Lemmens B, Arijs I, Van Assche G, et al. Correlation between the endoscopic and histologic score in assessing the activity of ulcerative colitis. Inflamm Bowel Dis. 2013;19:1194–1201. doi:10.1097/MIB.0b013e318280e75f23518809
   PubMed Web of Science ®Google Scholar
• Pai RK, Jairath V, Vande Casteele N, et al. The emerging role of histologic disease activity assessment in ulcerative colitis. Gastrointest Endosc. 2018;88:887–898. doi:10.1016/j.gie.2018.08.01830142351
   PubMed Web of Science ®Google Scholar
• Park S, Abdi T, Gentry M, et al. Histological disease activity as a predictor of clinical relapse among patients with ulcerative colitis: systematic review and meta-analysis. Am J Gastroenterol. 2016;111:1692–1701. doi:10.1038/ajg.2016.41827725645
   PubMed Web of Science ®Google Scholar
• Zenlea T, Yee EU, Rosenberg L, et al. Histology grade is independently associated with relapse risk in patients with ulcerative colitis in clinical remission: A prospective study. Am J Gastroenterol. 2016;111:685–690. doi:10.1038/ajg.2016.5026977756
   PubMed Web of Science ®Google Scholar
• Gupta RB, Harpaz N, Itzkowitz S, et al. Histologic inflammation is a risk factor for progression to colorectal neoplasia in ulcerative colitis: a cohort study. Gastroenterology. 2007;133:1099–105; quiz 1340. doi:10.1053/j.gastro.2007.08.001
   Web of Science ®Google Scholar
• Calafat M, Lobatón T, Hernández-Gallego A, et al. Acute histological inflammatory activity is associated with clinical relapse in patients with ulcerative colitis in clinical and endoscopic remission. Dig Liver Dis. 2017;49:1327–1331. doi:10.1016/j.dld.2017.08.04128958412
   PubMedGoogle Scholar
• Peyrin-Biroulet L, Bressenot A, Kampman W. Histologic remission: the ultimate therapeutic goal in ulcerative colitis? Clin Gastroenterol Hepatol. 2014;12:929–34.e2. doi:10.1016/j.cgh.2013.07.02223911875
   PubMed Web of Science ®Google Scholar
• Frøslie KF, Jahnsen J, Moum BA, et al. Mucosal healing in inflammatory bowel disease: results from a Norwegian population-based cohort. Gastroenterology. 2007;133:412–422. doi:10.1053/j.gastro.2007.05.05117681162
   PubMed Web of Science ®Google Scholar
• Christensen B, Erlich J, Gibson PR, et al. Histologic healing is more strongly associated with clinical outcomes in ileal Crohn’s disease than endoscopic healing. Clin Gastroenterol Hepatol. 2019. doi:10.1016/j.cgh.2019.11.056
   Web of Science ®Google Scholar
• Colman RJ, Rubin DT. Histological inflammation increases the risk of colorectal neoplasia in ulcerative colitis: a systematic review. Intest Res. 2016;14:202–210. doi:10.5217/ir.2016.14.3.20227433141
   PubMed Web of Science ®Google Scholar
• Rubin DT, Huo D, Kinnucan JA, et al. Inflammation is an independent risk factor for colonic neoplasia in patients with ulcerative colitis: a case-control study. Clin Gastroenterol Hepatol. 2013;11:1601–8.e1. doi:10.1016/j.cgh.2013.06.02323872237
   PubMed Web of Science ®Google Scholar
• Osterman MT, Scott FI, Fogt FF, et al. Endoscopic and histological assessment, correlation, and relapse in clinically quiescent ulcerative colitis (MARQUEE). Inflamm Bowel Dis. 2020. doi:10.1093/ibd/izaa048
   Web of Science ®Google Scholar
• Olén O, Askling J, Sachs MC, et al. Mortality in adult-onset and elderly-onset IBD: a nationwide register-based cohort study 19642014. Gut. 2019.
   Web of Science ®Google Scholar
• Olén O, Askling J, Sachs MC, et al. Childhood onset inflammatory bowel disease and risk of cancer: a Swedish nationwide cohort study 19642014. BMJ. 2017;358:j3951. doi:10.1136/bmj.j395128931512
   PubMed Web of Science ®Google Scholar
• Barlow L, Westergren K, Holmberg L, et al. The completeness of the Swedish cancer register: a sample survey for year 1998. Acta Oncol. 2009;48:27–33. doi:10.1080/0284186080224766418767000
   PubMed Web of Science ®Google Scholar
• Ludvigsson JF, Andersson M, Bengtsson J, et al. Swedish Inflammatory Bowel Disease Register (SWIBREG) - a nationwide quality register. Scand J Gastroenterol. 2019;54:1089–1101. doi:10.1080/00365521.2019.166079931498717
   PubMed Web of Science ®Google Scholar
• Ludvigsson JF, Lashkariani M. Cohort profile: ESPRESSO (Epidemiology Strengthened by histoPathology Reports in Sweden). Clin Epidemiol. 2019;11:101–114. doi:10.2147/CLEP.S19191430679926
   PubMed Web of Science ®Google Scholar
• Ludvigsson JF, Montgomery SM, Ekbom A, et al. Small-intestinal histopathology and mortality risk in celiac disease. JAMA. 2009;302:1171–1178. doi:10.1001/jama.2009.132019755695
   PubMed Web of Science ®Google Scholar
• Ludvigsson JF, Brandt L, Montgomery SM. Symptoms and signs in individuals with serology positive for celiac disease but normal mucosa. BMC Gastroenterol. 2009;9:57. doi:10.1186/1471-230X-9-5719624815
   PubMed Web of Science ®Google Scholar
• Bozorg SR, Song M, Emilsson L, et al. Validation of serrated polyps (SPs) in Swedish pathology registers. BMC Gastroenterol. 2019;20:3. doi:10.1186/s12876-019-1134-631892305
   PubMed Web of Science ®Google Scholar
• Svensson M, Bergman D, Olén O, et al. Validating microscopic colitis (MC) in Swedish pathology registers. Scand J Gastroenterol. 2018;53:1469–1475. doi:10.1080/00365521.2018.154344630600733
   PubMed Web of Science ®Google Scholar
• Ludvigsson JF, Andersson E, Ekbom A, et al. External review and validation of the Swedish national inpatient register. BMC Public Health. 2011;11:450. doi:10.1186/1471-2458-11-45021658213
   PubMed Web of Science ®Google Scholar
• Ludvigsson JF, Otterblad-Olausson P, Pettersson BU, et al. The Swedish personal identity number: possibilities and pitfalls in healthcare and medical research. Eur J Epidemiol. 2009;24:659–667. doi:10.1007/s10654-009-9350-y19504049
   PubMed Web of Science ®Google Scholar
• Jakobsson GL, Sternegård E, Olén O, et al. Validating inflammatory bowel disease (IBD) in the Swedish National Patient Register and the Swedish Quality Register for IBD (SWIBREG). Scand J Gastroenterol. 2017;52:216–221. doi:10.1080/00365521.2016.124660527797278
   PubMed Web of Science ®Google Scholar
• Shrestha S, Olén O, Eriksson C, et al. The use of ICD codes to identify IBD subtypes and phenotypes of the montreal classification in the swedish national patient register. Scand J Gastroenterol. 2020;1–6.
   Web of Science ®Google Scholar
• Olén O, Erichsen R, Sachs MC, et al. Colorectal cancer in ulcerative colitis: a Scandinavian population-based cohort study. Lancet. 2020;395:123–131. doi:10.1016/S0140-6736(19)32545-031929014
   PubMed Web of Science ®Google Scholar
• Schroeder KW, Tremaine WJ, Ilstrup DM. Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis. Randomized Study N Engl J Med. 1987;317:1625–1629. doi:10.1056/NEJM1987122431726033317057
   PubMed Web of Science ®Google Scholar
• Letham B, Rudin C, McCormick TH, et al. Interpretable classifiers using rules and Bayesian analysis: building a better stroke prediction model. Ann Appl Stat. 2015;9:1350–1371. doi:10.1214/15-AOAS848
   Web of Science ®Google Scholar
• Friedman J, Hastie T, Tibshirani R. Regularization paths for generalized linear models via coordinate descent. J Stat Softw. 2010;33:1–22. doi:10.18637/jss.v033.i0120808728
   PubMed Web of Science ®Google Scholar
• Yang H, Rudin C, Seltzer M. Scalable bayesian rule lists. arXiv. 2016.
   Google Scholar
• Sachs MC. plotROC: A Tool for Plotting ROC Curves. J Stat Softw. 2017;79.
   Web of Science ®Google Scholar
• Therneau TM. Survival Analysis [R package survival version 3. 1–12].
   Google Scholar
• Hu AB, Tan W, Deshpande V, et al. Ileal or colonic histologic activity is not associated with clinical relapse in patients with Crohn’s disease in endoscopic remission. Clin Gastroenterol Hepatol. 2020. doi:10.1016/j.cgh.2020.04.050
   Web of Science ®Google Scholar
• Theede K, Holck S, Ibsen P, et al. Level of fecal calprotectin correlates with endoscopic and histologic inflammation and identifies patients with mucosal healing in ulcerative colitis. Clin Gastroenterol Hepatol. 2015;13:1929–36.e1. doi:10.1016/j.cgh.2015.05.03826051392
   PubMed Web of Science ®Google Scholar
• Irani NR, Wang LM, Collins GS, et al. Correlation between endoscopic and histological activity in ulcerative colitis using validated indices. J Crohns Colitis. 2018;12:1151–1157. doi:10.1093/ecco-jcc/jjy08129893824
   PubMed Web of Science ®Google Scholar
• Christensen B, Hanauer SB, Erlich J, et al. Histologic normalization occurs in ulcerative colitis and is associated with improved clinical outcomes. Clin Gastroenterol Hepatol. 2017;15:1557–1564.e1. doi:10.1016/j.cgh.2017.02.01628238954
   PubMed Web of Science ®Google Scholar
• Mosli MH, Feagan BG, Zou G, et al. Development and validation of a histological index for UC. Gut. 2017;66:50–58. doi:10.1136/gutjnl-2015-31039326475633
   PubMed Web of Science ®Google Scholar
• Marchal-Bressenot A, Salleron J, Boulagnon-Rombi C, et al. Development and validation of the Nancy histological index for UC. Gut. 2017;66:43–49. doi:10.1136/gutjnl-2015-31018726464414
   PubMed Web of Science ®Google Scholar
• Geboes K, Riddell R, Ost A, et al. A reproducible grading scale for histological assessment of inflammation in ulcerative colitis. Gut. 2000;47:404–409. doi:10.1136/gut.47.3.40410940279
   PubMed Web of Science ®Google Scholar